Patent intelligence · US
US 11426348
Compositions of bupivacaine multivesicular liposomes
Compositions of bupivacaine multivesicular liposomes
Patent details — US 11426348
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 30, 2022
- Expiration
- Aug 25, 2042
- Applicant
- Pacira Pharmaceuticals, Inc.
- Claims
- 58
- CPC classes
- A61K, A61K31/445, A61K47/12, A61K47/14
Quick answer
US 11426348 (Compositions of bupivacaine multivesicular liposomes) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Aug 30, 2022. Expires Aug 25, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Pacira Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 58
- CPC classes
- A61K, A61K31/445, A61K47/12, A61K47/14, A61K47/183, A61K47/26
More from Pacira Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12370142
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12364764
Sustained release thermosetting gels comprising sodium channel blockers and the methods of making same
granted -
US 12318483
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12296047
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12285435
Multivesicular liposome formulations of dexamethasone
granted -
US 12285419
Bupivacaine multivesicular liposome formulations and uses thereof
granted -
US 12280149
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12251472
Manufacturing of bupivacaine multivesicular liposomes
granted
Frequently asked questions
What is US patent 11426348?
US 11426348 (Compositions of bupivacaine multivesicular liposomes) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Aug 30, 2022. Expires Aug 25, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11426348?
Pacira Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.
When does US 11426348 expire?
Our index shows an expiration date of Aug 25, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.